NCT06789159
- Conditions
- DNA Virus Infections, Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +6 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
Clinical trial condition
Diffuse Large B Cell Lymphoma Relapsed
Explore clinical trials studying Diffuse Large B Cell Lymphoma Relapsed. Study availability and eligibility vary by location and protocol.
6 public trials
5 recruiting studies
Diffuse Large B Cell Lymphoma Relapsed trial results
NCT07478848
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +13 more
- Locations
-
- Abramson Cancer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT06703892
- Conditions
- Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Follicular Lymphoma ( FL), +13 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT07188558
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +16 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Scottsdale, Arizona, United States
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- University of Arkansas Little Rock, Arkansas, United States
Recruiting
Immunotherapy in Lymphoma
NCT06796517
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma Relapsed, +22 more
- Locations
-
- Seoul St. Mary Hospital Seoul, South Korea
- Yeoido St. Mary Hospital Seoul, South Korea
NCT02142049
- Conditions
- Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- SITE-1 Duarte, California, United States
- SITE-2 Los Angeles, California, United States
- SITE-10 Orange, California, United States
- SITE-3 Chicago, Illinois, United States